VCEL information

Here’s an informative Bloomberg article regarding Vericel (VCEL) a promising biotech company:

I had posted about this company back in May:…

As stated, I established my position at prices between $11 - $12. Today, the shares are selling for $14. That’s roughly a 20% increase in 5 months. Investor sentiment seems positive, the technicals are good, and the company is receiving attention. It’s volatile and I doubt I’ll be increasing my position size, but I wanted to add a bit of diversity to my portfolio and this company fit the bill (TRXC is another diversity play - but that’s a different story).

May we all live long and prosper.